# Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

> **NCT00200538** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Dementia

## Interventions

- **DRUG:** memantine

## Key facts

- **NCT ID:** NCT00200538
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2013-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200538, "Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00200538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*